During this year´s AACR Annual Meeting, Washington DC, April 6 -10, ecancer caught up with VHIO´s Laura Soucek, PI of the Mouse Models of Cancer Therapies Group, to discuss her group´s pioneering work on Myc inihibition in pre-clinical mouse models.
Related Posts
Biosimilars create opportunities for sustainable cancer care
Source: the European Society for Medical Oncology (ESMO) Lugano, Switzerland, 18 January, 2017 – Biosimilars create opportunities for sustainable cancer…
18 Jan 2017
WIN Consortium and Pfizer Collaborate to Advance Personalized Cancer Care
The Worldwide Innovative Network (WIN) in personalized cancer medicine consortium, of which the Vall d´Hebron Institute of Oncology (VHIO) is…
17 Dec 2012
Immediate Call for Oustanding Principal Investigators in Basic/Translational Cancer Research & Immunology
The Vall d´Hebron Institute of Oncology (VHIO), invites immediate applications from outstanding individuals to establish and maintain energetic, independent and…
30 Dec 2013
ASCO Annual Meeting 2012: Largest study on women with breast cancer treated with PI3K inhibitors
ASCO Annual Meeting 2012: Largest study on women with breast cancer treated with PI3K inhibitors.
– The study was presented at the annual meeting of ASCO (American Society of Clinical Oncology) revealing findings surrounding the largest sample of breast cancer patients treated with this group of drugs.
– This research presented at ASCO was honored through a Merit Award from the Conquer Cancer Foundation — testament to its high quality and important scientific interest.
06 Jun 2012
VHIO´s Joan Seoane elected as Fellow of the prestigious European Academy of Cancer Sciences
Launched back in 2009, the European Academy of Cancer Sciences, presided by Alexander M.M. Eggermont, also Director General of Gustave…
16 Oct 2017
European cancer centers of excellence: powering long-term collaborative partnerships.
For many decades, cancer research in Europe has been heavily fragmented, inefficient and duplicating work. Now, long-term collaborations have been…
11 Dec 2015
Third generation PAM50-based genomic test: more precisely predicting response to anti-cancer therapy
Published today in the journal Clinical Cancer Research, results from an international multi-center study led by Aleix Prat, Principal Investigator…
30 Nov 2016
An interview with Paolo Nuciforo: Vision towards Precision Oncology
Recently published as an invited article in Cellular Oncology, Paolo Nuciforo, Principal Investigator of the Vall d’Hebron Institute of Oncology…
24 Nov 2014
VHIO: first academic research center to use liquid biopsy RAS biomarker testing technology
Source: Merck Serono Merck Serono and Sysmex Inostics Announce First Liquid Biopsy RAS Biomarker Testing Center Opens: Important Milestone for…
20 Feb 2015
´We can. I can´: World Cancer Day 04 February 2016
World Cancer Day (WCD), 04 February 2016, marks the launch of a new three-year campaign implemented and led by the…
14 Jan 2016
VHIO Meet the Editors with Annals of Oncology´s Jean-Charles Soria, Monday 08 September 2014
Taking place on Monday 08 September 2014, beginning with a Welcome coffee at 14:15 – 14:30, followed by the main…
27 Jun 2014
Novel biomarker identified for monitoring response to colorectal cancer therapy in plasma
Recent VHIO study reveals that tumor cell sensitivity and resistance to therapy with cetuximab in colorectal cancer can be detected…
30 Oct 2014
A genetic test at the time of diagnosis, useful for predicting treatment response in breast cancer
Source: Hospital Clínic Researchers at Hospital Clínic and IDIBAPS lead a study in which a genomic test performed at the…
13 Jan 2016
ESMO 2019 Annual Congress to be held in Barcelona
Source: European Society for Medical Oncology (ESMO) ESMO, the leading European professional organisation for medical oncology, has announced that the…
13 Jun 2017
VHIO´s 2016 Scientific Report now launched: in print, extended version online, and available for downloading in PDF
Celebrating VHIO´s 10th birthday, our 2016 Scientific Report is themed Turning ten and defining ´next-gen´ directions, and is now available…
10 May 2017
